Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Menter

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Expert Opinion on Investigational Drugs|November 30, 2002
Cyclooxygenase 2 selective inhibitors in cancer treatment and preventionDavid G Menter
International Journal of Cell Biology|April 17, 2012
Prostaglandins in cancer cell adhesion, migration, and invasionDavid G Menter, Raymond N Dubois
Annual Review of Pharmacology and Toxicology|October 6, 2022
An Aspirin a Day: New Pharmacological Developments and Cancer ChemopreventionDavid G Menter, Robert S Bresalier
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular SubtypesMichael S Lee, David G Menter, Scott Kopetz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the rewardDavid G Menter, Richard L Schilsky, Raymond N DuBois
Cancer Metastasis Reviews|July 2, 2017
Platelets, circulating tumor cells, and the circulomePreeti Kanikarla-Marie, Michael Lam, David G Menter, et al.
NPJ Precision Oncology|June 7, 2018
Endothelial cell malignancies: new insights from the laboratory and clinicMichael J Wagner, Vinod Ravi, David G Menter, et al.
Journal of Morphology|September 12, 2018
Leucophores and iridophores of Fundulus heteroclitus: Biophysical and ultrastructural propertiesDavid G Menter, M Obika, T T Tchen, et al.
Seminars in Oncology|March 13, 2016
Mechanisms of nonsteroidal anti-inflammatory drugs in cancer preventionAsad Umar, Vernon E Steele, David G Menter, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cellsAnita L Sabichi, Vemparala Subbarayan, Norma Llansa, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Expert Opinion on Investigational Drugs|November 30, 2002
Cyclooxygenase 2 selective inhibitors in cancer treatment and preventionDavid G Menter
International Journal of Cell Biology|April 17, 2012
Prostaglandins in cancer cell adhesion, migration, and invasionDavid G Menter, Raymond N Dubois
Annual Review of Pharmacology and Toxicology|October 6, 2022
An Aspirin a Day: New Pharmacological Developments and Cancer ChemopreventionDavid G Menter, Robert S Bresalier
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular SubtypesMichael S Lee, David G Menter, Scott Kopetz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the rewardDavid G Menter, Richard L Schilsky, Raymond N DuBois
Cancer Metastasis Reviews|July 2, 2017
Platelets, circulating tumor cells, and the circulomePreeti Kanikarla-Marie, Michael Lam, David G Menter, et al.
NPJ Precision Oncology|June 7, 2018
Endothelial cell malignancies: new insights from the laboratory and clinicMichael J Wagner, Vinod Ravi, David G Menter, et al.
Journal of Morphology|September 12, 2018
Leucophores and iridophores of Fundulus heteroclitus: Biophysical and ultrastructural propertiesDavid G Menter, M Obika, T T Tchen, et al.
Seminars in Oncology|March 13, 2016
Mechanisms of nonsteroidal anti-inflammatory drugs in cancer preventionAsad Umar, Vernon E Steele, David G Menter, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cellsAnita L Sabichi, Vemparala Subbarayan, Norma Llansa, et al.
Pageof 7